| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/19/2001 | WO2001027097A1 Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027088A1 Lpl potentiators |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027082A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001027070A1 Use of carbonylamino derivatives against cns disorders |
| 04/19/2001 | WO2001026678A1 Short segments of dap-kinase |
| 04/19/2001 | WO2001026676A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026658A2 Topical nasal treatment using desloratadine |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026654A1 Fab i inhibitors |
| 04/19/2001 | WO2001026653A1 V TYPE AND/OR X TYPE sPLA2 INHIBITORS |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026648A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 04/19/2001 | WO2001026645A1 Method for protecting normal cells from cytotoxicity of chemotherapeutic agents |
| 04/19/2001 | WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/19/2001 | WO2001026637A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 04/19/2001 | WO2001026629A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026625A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026623A2 Treatment of fatigue, head injury and stroke |
| 04/19/2001 | WO2001026618A2 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/19/2001 | WO2001026481A1 Fish feed with increased nucleotide content |
| 04/19/2001 | WO2001026467A1 Methods of enhancing chemotherapy |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000067762A3 Selenium-containing pro-drugs for cancer therapy |
| 04/19/2001 | WO2000061132A8 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
| 04/19/2001 | WO2000046198A8 Anti-inflammatory indole derivatives |
| 04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 04/19/2001 | WO1998008546A8 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/19/2001 | US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis |
| 04/19/2001 | US20010000340 New uses for corticotropin releasing factor antagonists |
| 04/19/2001 | DE4244342C2 Benzofuranylimidazolderivate, Verfahren zur Herstellung und therapeutische Präparate, die dieselben enthalten Benzofuranylimidazolderivate, methods of preparation and therapeutic compositions containing the same |
| 04/19/2001 | DE19947668A1 Tumorspezifischer Vektor für die Gentherapie A tumor-specific vector for gene therapy |
| 04/19/2001 | CA2399093A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | CA2388991A1 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2388232A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | CA2388224A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | CA2387604A1 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386821A1 3-aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| 04/19/2001 | CA2386804A1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2386299A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | CA2386164A1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385123A1 Method of altering polypeptide aggregation |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2383970A1 Topical nasal treatment using desloratadine |
| 04/19/2001 | CA2382727A1 Methods of enhancing chemotherapy with the use of an imidazole |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/19/2001 | CA2381297A1 Pyrrolo¬2,3-d|pyrimidine nucleoside analogs |
| 04/19/2001 | CA2355357A1 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/18/2001 | EP1092777A1 Self-cleaving RNA sequences and their use for the control of protein synthesis. |
| 04/18/2001 | EP1092728A2 Biologically digestable complex of orthosilicic acid in a solid, stable and concentrated form and proces for its preparation |
| 04/18/2001 | EP1092727A2 G-protein receptor |
| 04/18/2001 | EP1092719A2 Imidazo[5,1-f][1,2,4]triazine derivatives |
| 04/18/2001 | EP1092718A1 2-(2-Alkoxy-5-heterocyclylsulphonylphenyl)purin-6-ones as phosphodiesterase inhibitors |
| 04/18/2001 | EP1092717A2 Polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092716A2 Derivatives of benzothiophenes, benzofurans and indoles, method for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same |
| 04/18/2001 | EP1092431A2 Lasofoxifene compositions |
| 04/18/2001 | EP1092430A1 Non-chlorofluorocarbon aerosol formulations |
| 04/18/2001 | EP1092423A2 Use of DHEA or its precursors and metabolites as skin depigmentation agents |
| 04/18/2001 | EP1092035A2 Targeted integration into chromosomes using retroviral vectors |
| 04/18/2001 | EP1092032A2 Human oxidoreductase proteins |
| 04/18/2001 | EP1092029A1 A novel human thrombopoietin mutein |
| 04/18/2001 | EP1092025A1 Human emr1-like g protein coupled receptor |
| 04/18/2001 | EP1092023A2 Molecules associated with apoptosis |
| 04/18/2001 | EP1092022A2 Immune system molecules |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1091974A2 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 04/18/2001 | EP1091966A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 04/18/2001 | EP1091962A1 Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 04/18/2001 | EP1091959A1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament |
| 04/18/2001 | EP1091956A1 Muscarinic antagonists |
| 04/18/2001 | EP1091955A1 Quinolones as serine protease inhibitors |
| 04/18/2001 | EP1091954A1 Process for producing (8- chloro-3,10- dibromo-6,11- dihydro- 5h-benzo 5,6]cyclohepta 1,2-b]pyridin-11-yl)- 1-piperidine |
| 04/18/2001 | EP1091953A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 04/18/2001 | EP1091950A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 04/18/2001 | EP1091949A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 04/18/2001 | EP1091948A2 Tubulin binding compounds (cobra) |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP1091938A2 Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | EP1091934A2 Alkyl ketones as potent anti-cancer agents |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |